Gain Therapeutics Director Dov Goldstein Receives Award

What Happened
Dov A. Goldstein, M.D., a director of Gain Therapeutics, was granted a 25,000-share derivative award on 2026-07-15. The filing reports an acquisition of 25,000 shares at a $0.00 price (total reported value $0). This was an award/grant (not a market purchase or sale).

Key Details

• Transaction date: 2026-07-15; Form 4 filed 2026-07-17 (within the typical 2‑business‑day reporting window).
• Instrument: Derivative award (25,000 shares) reported at $0.00.
• Shares owned after transaction: Not specified in the Form 4 filing.
• Footnote: The award vests in 12 equal monthly installments beginning July 24, 2026, subject to continuous service.
• No indication of a 10b5-1 plan, cashless exercise, or tax‑withholding sale in this filing.

Context
This is a grant/award to a director rather than an open‑market buy or sale. The reported $0.00 means the filing shows no cash paid at grant; the award will vest over time and may convert to actual shares or options per plan terms. Director grants are common as part of compensation and do not by themselves indicate immediate buying or selling intent.